BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17384358)

  • 1. Atorvastatin-induced early-onset rhabdomyolysis in a patient with nephrotic syndrome.
    Jose J; Saravu K; Shastry BA
    Am J Health Syst Pharm; 2007 Apr; 64(7):726-9. PubMed ID: 17384358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyolysis in a patient treated with colchicine and atorvastatin.
    Tufan A; Dede DS; Cavus S; Altintas ND; Iskit AB; Topeli A
    Ann Pharmacother; 2006; 40(7-8):1466-9. PubMed ID: 16772404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    Lewin JJ; Nappi JM; Taylor MH
    Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
    Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
    Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
    Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
    Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
    [No Abstract]   [Full Text] [Related]  

  • 7. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
    Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
    Maltz HC; Balog DL; Cheigh JS
    Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin-associated acute interstitial nephritis and rhabdomyolysis.
    Panchangam V
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):659-60. PubMed ID: 24821172
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Ronaldson KJ; O'Shea JM; Boyd IW
    Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].
    Rubí S; Duch J; Ortín J; Setoain X; Pons F
    Rev Esp Med Nucl; 2006; 25(6):393. PubMed ID: 17173790
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
    Cannon CS
    JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin.
    Grosso F; D'Incalci M
    Tumori; 2011; 97(2):256. PubMed ID: 21617728
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of alternate-day dosing versus daily dosing of atorvastatin.
    Jafari M; Ebrahimi R; Ahmadi-Kashani M; Balian H; Bashir M
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):123-6. PubMed ID: 12808485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
    Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A
    Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients.
    Newman CB; Palmer G; Silbershatz H; Szarek M
    Am J Cardiol; 2003 Sep; 92(6):670-6. PubMed ID: 12972104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-associated rhabdomyolysis: is there a dose-response relationship?
    Holbrook A; Wright M; Sung M; Ribic C; Baker S
    Can J Cardiol; 2011; 27(2):146-51. PubMed ID: 21459261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
    Mah Ming JB; Gill MJ
    AIDS Patient Care STDS; 2003 May; 17(5):207-10. PubMed ID: 12816614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.